BioRx Offers Berinert(R) to Patients with Hereditary Angioedema

Published: Dec 08, 2009

Bookmark and Share

CINCINNATI--(BUSINESS WIRE)--BioRx, a specialty pharmacy company, has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their distribution network to launch this exciting new product in the United States.

Back to news